69 related articles for article (PubMed ID: 9925280)
1. GM2-GM3 gangliosides ratio is dependent on GRP94 through down-regulation of GM2-AP cofactor in brain metastasis cells.
Bedia C; Badia M; Muixí L; Levade T; Tauler R; Sierra A
Sci Rep; 2019 Oct; 9(1):14241. PubMed ID: 31578452
[TBL] [Abstract][Full Text] [Related]
2. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.
Livingston PO; Ritter G; Calves MJ
Cancer Immunol Immunother; 1989; 29(3):179-84. PubMed ID: 2731184
[TBL] [Abstract][Full Text] [Related]
3. Unique gangliosides synthesized in vitro by sialyltransferases from marine bacteria and their characterization: ganglioside synthesis by bacterial sialyltransferases.
Kamimiya H; Suzuki Y; Kasama T; Kajiwara H; Yamamoto T; Mine T; Watarai S; Ogura K; Nakamura K; Tsuge J; Kushi Y
J Lipid Res; 2013 Mar; 54(3):571-580. PubMed ID: 23220479
[TBL] [Abstract][Full Text] [Related]
4. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.
Regina Todeschini A; Hakomori SI
Biochim Biophys Acta; 2008 Mar; 1780(3):421-33. PubMed ID: 17991443
[TBL] [Abstract][Full Text] [Related]
5. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Duivenvoorden WC; Hirte HW; Singh G
Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative constituents from umbelliferae plants. V. A new furanocoumarin and falcarindiol furanocoumarin ethers from the root of Angelica japonica.
Fujioka T; Furumi K; Fujii H; Okabe H; Mihashi K; Nakano Y; Matsunaga H; Katano M; Mori M
Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):96-100. PubMed ID: 9987830
[TBL] [Abstract][Full Text] [Related]
7. In vitro tumor growth inhibition by syngeneic lymphocytes and/or macrophages.
Fidler IJ; Peterson DE
Adv Exp Med Biol; 1976; 73 Pt B():389-95. PubMed ID: 998402
[No Abstract] [Full Text] [Related]
8. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.
Batliwalla FM; Bateman BA; Serrano D; Murray D; Macphail S; Maino VC; Ansel JC; Gregersen PK; Armstrong CA
Mol Med; 1998 Dec; 4(12):783-94. PubMed ID: 9990864
[TBL] [Abstract][Full Text] [Related]
9. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Papadakis JA; Mikhailidis DP
JAMA; 1999 Feb; 281(5):416; author reply 417-9. PubMed ID: 9952196
[No Abstract] [Full Text] [Related]
10. A pilot experiment to compare regression of transplants of two different human tumors in athymic nude mice following single exposures to 60co radiation.
Brustad T; Rofstad EK; Davy M; Mossige J
Strahlentherapie; 1976 Nov; 152(5):477-81. PubMed ID: 996892
[TBL] [Abstract][Full Text] [Related]
11. Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes.
Glovanella BC; Stehlin JS; Santamaria C; Yim SO; Morgan AC; Williams LJ; Leibovitz A; Fialkow PJ; Mumford DM
J Natl Cancer Inst; 1976 Jun; 56(6):1131-42. PubMed ID: 994214
[TBL] [Abstract][Full Text] [Related]
12. Potential CNS antitumor agents--phenothiazines I: Nitrogen mustard derivatives.
Hirata T; Driscoll JS
J Pharm Sci; 1976 Nov; 65(11):1699-701. PubMed ID: 994007
[TBL] [Abstract][Full Text] [Related]
13. Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases.
Fanburg-Smith JC; Hengge M; Hengge UR; Smith JS; Miettinen M
Ann Diagn Pathol; 1998 Dec; 2(6):351-62. PubMed ID: 9930572
[TBL] [Abstract][Full Text] [Related]
14. Strategies for the development of vaccines to treat breast cancer.
Jäger E; Jäger D; Knuth A
Recent Results Cancer Res; 1998; 152():94-102. PubMed ID: 9928550
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumour growth in vivo and in vitro by prostaglandin E.
Santoro MG; Philpott GW; Jaffe BM
Nature; 1976 Oct; 263(5580):777-9. PubMed ID: 995190
[No Abstract] [Full Text] [Related]
16. Chemical, metabolic and immunological characterization of gangliosides of human glioma cells.
Maeda Y; Yamaki T; Yoshikawa J; Tatewaki K; Piao H; Yu H; Ibayashi Y; Hashi K
Cancer Biochem Biophys; 1998 Nov; 16(4):313-32. PubMed ID: 9925280
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of gangliosides from Trypanosoma brucei.
Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
J Parasitol; 2004 Feb; 90(1):123-7. PubMed ID: 15040678
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
19. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
